PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
01-Oct-2024 IBRILATAZAR (ABTL0812) from AbilityPharma increases chemotherapy effectiveness by 40% in patients with endometrial cancer AbilityPharma
01-Oct-2024 Ablation Technologies Market Size to Hit USD 13903 Million by 2032 Driven By Growing Demand For Minimally Invasive Treatment - Acumen Research And Consulting Acumen Research And Consulting
01-Oct-2024 Lynred demonstrates smallest thermal imaging sensor for future AutomaticEmergency Braking Systems (AEB) at AutoSens Europe Andrew Lloyd Associates
01-Oct-2024 easyXAFS Upgrades Their Service to Include a Bioz Content Hub, Enhancing Research Discovery AccessWire
01-Oct-2024 Drägerwerk AG & Co. KGaA: Notification pursuant to Art. 5 (1) of the Regulation (EU) No 596/2014 and Art. 2 (1) of the Delegated Regulation (EU) 2016/1052 of the Commission Drägerwerk AG & Co. KGaA
01-Oct-2024 In Vitro Diagnostics Market Size to Worth Around USD 119.4 Billion by 2029 | CAGR 6.9% Marketsandmarkets
01-Oct-2024 Clinical Trials Market Size to Worth Around USD 73.2 Billion by 2028 | CAGR 8.7% Marketsandmarkets
01-Oct-2024 Remote Patient Monitoring Market Size to Worth Around USD 207.5 Billion by 2028 | CAGR 23.6% Marketsandmarkets
01-Oct-2024 Home Healthcare Market Size to Worth Around USD 383 Billion by 2028 | CAGR 8.9% Marketsandmarkets
01-Oct-2024 PharmaSGP Holding SE has purchased 477,701 own shares through its public share repurchase offer PharmaSGP Holding SE
01-Oct-2024 How to Find the Best Clinical Research Course for Your Career Goals Fusion technology solutions
01-Oct-2024 ATPC and FORMEDIC Technologies Announce Strategic Collaboration to Launch LEGA, a Revolutionary Respiratory Care Device AccessWire
01-Oct-2024 Moderna and Cenra Healthcare Enter Joint Agreement to Promote Moderna’s mRNA Respiratory Vaccine Portfolio in Taiwan, Including COVID-19 Vaccines AccessWire
30-Sep-2024 Biophytis Publishes First-Half Financial Results and Provides an Update on its Business Activities AccessWire
30-Sep-2024 Biophytis Publishes First-Half Financial Results and Provides an Update on its Business Activities Biophytis
30-Sep-2024 Xlife Sciences AG enables international co-investors to enter the stock and is planning a dual listing on the London Stock Exchange Group (LSEG) Xlife Sciences AG
30-Sep-2024 IGI Announces CRADA with National Cancer Institute to Test Proprietary Oral Cbl/b Inhibitor Treatment in Triple Negative Breast Cancer Ichnos Glenmark Innovation (IGI),
30-Sep-2024 Olympus Launches VISERA S, a New Imaging Platform Olympus Corp
30-Sep-2024 European Commission approves Yuvanci® (Single Tablet Combination Therapy [STCT] of Macitentan and Tadalafil) for Treatment of Patients with Pulmonary Arterial Hypertension (PAH) Johnson & Johnson
30-Sep-2024 CARVYKTI® ▼ (ciltacabtagene autoleucel; cilta-cel) is the first cell therapy to significantly extend overall survival versus standard therapies for patients with multiple myeloma as early as second line Janssen-Cilag